Abstract
Postmastectomy radiotherapy (PMRT) is accepted as the standard of care for women with early breast cancer with 4 or more involved axillary nodes. However the role of PMRT in women with 1–3 involved nodes remains controversial and guidelines vary.
We present the arguments against advocating postmastectomy radiotherapy for all women with node positive breast cancer.
We present the arguments against advocating postmastectomy radiotherapy for all women with node positive breast cancer.
Original language | English |
---|---|
Pages (from-to) | 2515-2520 |
Number of pages | 6 |
Journal | European Journal of Surgical Oncology (EJSO) |
Volume | 47 |
Issue number | 10 |
DOIs | |
Publication status | Published - 28 Jun 2021 |
Keywords / Materials (for Non-textual outputs)
- postmastectomy radiotherapy
- breast cancer